When did this incident occur?

The incident is recorded as occurring on July 1, 2026 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.

Incident · Regulatory action

FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal procedures

CMR Surgical secured FDA 510(k) clearance for its Versius Plus minimally invasive robotic surgical system, indicated for gallbladder removal procedures. The modular system can be moved between hospital departments. CMR plans US commercialization in 2026, following a $200M equity and debt investment in April 2026.

Occurred 2026-07-01 · CMR Surgical · Investigated by FDA

How to read this record

Incident records on DEPLOY are compiled from public sources (regulatory filings, news reports, and operator disclosures) and reflect what has been reported and tracked to date. They are not legal findings, determinations of fault, or safety ratings, and may be updated as new information is verified. See the sources below for the underlying references.

Track FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal procedures

Machine-readable surfaces

Markdown mirror: /incidents/fda-510k-cmr-versius-plus-clearance.md
JSON-LD: embedded in this page’s head
REST API: /v1/incidents/86a754c6-f41a-4165-86e6-6c5b110ef5ab
Data documentation: /data
Query this programmatically: Deploy MCP

Sources (1)

Medical Device Network · https://www.medicaldevice-network.com/news/fda-clears-cmr-surgical-versius-plus-robot/ · 2026-07-01

Status history

Active · 2026-07-23 · agent:recon

Common questions

What happened in FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal procedures?: CMR Surgical secured FDA 510(k) clearance for its Versius Plus minimally invasive robotic surgical system, indicated for gallbladder removal procedures. The modular system can be moved between hospital departments. CMR plans US commercialization in 2026, following a $200M equity and debt investment in April 2026.
When did this incident occur?: The incident is recorded as occurring on July 1, 2026 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.
Who was involved in FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal procedures?: The incident is recorded as involving CMR Surgical on the DEPLOY registry. No specific robot model is linked to this incident in the registry.
Has anyone responded to FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal procedures?: No responses to this incident are recorded on the DEPLOY registry. Operators, manufacturers, or affected parties can submit responses to the editorial team; absence is not a guarantee no response was issued.
What is the current status of FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal procedures?: This incident is an active record on the DEPLOY registry; no retraction or correction has been issued.

Methodology: Unreviewed · 1 source (no primary) · last reviewed 2026-07-23

Verification posture

Unreviewed

Low confidence

Review state

Stable

Last reviewed 2026-07-23

Sources by quality tier

1: unclassified; Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Deploy Watch

Track this incident.

We notify you when the regulator updates the record, the remedy status changes, or a related incident surfaces.

Canonical ID 86a754c6-f41a-4165-86e6-6c5b110ef5ab